ArticleAmerican journal of preventive cardiology2027
External validation of artificial intelligence-guided electrocardiogram (AI-ECG) in detecting asymptomatic left ventricular dysfunction: A systematic review and meta-analysis.
Article in American journal of preventive cardiology, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in the Interpretation of the Electrocardiogram by Artificial Intelligence.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Asymptomatic left ventricular dysfunction (LVD) represents a key and frequently under-recognized stage in the heart failure (HF) continuum. Early identification enables targeted prevention and timely initiation of evidence-based therapies. Artificial intelligence-enabled electrocardiography (AI-ECG) may provide a scalable alternative to imaging for LVD detection. This systematic review synthesized evidence from exclusively externally validated AI-ECG studies evaluating the detection of asymptomatic LVD, with symptomatic HF cohorts included to contextualize the evidence base across the HF continuum. Methods: A systematic literature search was conducted on 8th September 2025. The main output was the pooled area under the receiver operating characteristic curve (AUROC). Results: From 3,587 records, 12 asymptomatic and 30 symptomatic studies were identified (538,735 participants). In asymptomatic cohorts evaluating left ventricular systolic dysfunction (LVSD), AI-ECG demonstrated promising but heterogeneous discriminatory performance (I²>85%) with pooled AUROCs of 0.87 (95% CI 0.75-0.99) for LVEF ≤35%, 0.93 (95% CI 0.88-0.97) for LVEF ≤40%, and 0.89 (95% CI 0.85-0.97) for LVEF ≤50%. Symptomatic cohorts showed AUROCs of 0.89 (95% CI 0.86-0.92), 0.90 (95% CI 0.88-0.92), and 0.85 (95% CI 0.83-0.86) respectively. Asymptomatic left ventricular diastolic dysfunction (LVDD) demonstrated moderate performance (AUROC 0.76, 95% CI 0.66-0.86) with no externally validated symptomatic LVDD studies identified. Small-study effects were detected exclusively in asymptomatic cohorts. Conclusions: Discriminatory performance of AI-ECG in asymptomatic LVSD is broadly comparable to symptomatic populations. High risk of bias driven by prolonged ECG-to-echocardiogram intervals reflecting real-world logistical constraints necessitate cautious interpretation of results and further prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.